Further potential insight into the complex neuropathology of Down's syndrome

Further potential insight into the complex neuropathology of Down’s syndrome
sorting nexin-27 [SNX27].

(Medical Xpress)—Researchers at the University of Bristol have revealed new insight into the function of a key protein attributed to impaired learning and memory in Down's syndrome. The findings, published online in Nature Cell Biology, offer further molecular insight into how the reduced level of this key protein termed 'sorting nexin-27' [SNX27] may contribute to learning and memory problems associated with Down's syndrome.

The Bristol-based team now reveal how SNX27 forms the core component of an ancient protein complex which functions to control the abundance of a select group of proteins at the surface of cells. Included among these proteins are numerous transporters that regulate the cell's ability to take up various nutrients, including glucose and such as zinc and copper. In cells lacking SNX27, the level of these transporters is reduced and the cell's ability to take up nutrients is adversely perturbed.

Peter Cullen, Professor of Biochemistry from the University's School of Biochemistry and senior author of the Wellcome Trust-funded study, said: "Besides the previously recognised role of SNX27 in regulating the synaptic activity of neurones, our study suggests that the lack of SNX27 expression observed in Down's syndrome may also lead to a reduced metabolic activity that may adversely affect and cognitive function.

"Further analysis of the effect of reduced SNX27 expression on the synaptic and metabolic activity of specific neuronal populations will certainly provide much needed molecular insight into the complex neuropathology of Down's syndrome as well as other neurological conditions."

More information: Steinberg F. et al. A global analysis of SNX27-retromer assembly and cargo specificity reveals a function in glucose and metal ion transport, Nature Cell Biology.

Related Stories

Loss of enzyme reduces neural activity in Angelman syndrome

Mar 04, 2010

Angelman Syndrome is a rare but serious genetic disorder that causes a constellation of developmental problems in affected children, including mental retardation, lack of speech, and in some cases, autism. Over a decade ago, ...

New mechanism for long-term memory formation discovered

Mar 25, 2013

UC Irvine neurobiologists have found a novel molecular mechanism that helps trigger the formation of long-term memory. The researchers believe the discovery of this mechanism adds another piece to the puzzle in the ongoing ...

Recommended for you

The impact of bacteria in our guts

11 hours ago

The word metabolism gets tossed around a lot, but it means much more than whether you can go back to the buffet for seconds without worrying about your waistline. In fact, metabolism is the set of biochemical ...

Stem cell therapies hold promise, but obstacles remain

12 hours ago

(Medical Xpress)—In an article appearing online today in the journal Science, a group of researchers, including University of Rochester neurologist Steve Goldman, M.D., Ph.D., review the potential and ch ...

New hope in fight against muscular dystrophy

13 hours ago

Research at Stockholm's KTH Royal Institute of Technology offers hope to those who suffer from Duchenne muscular dystrophy, an incurable, debilitating disease that cuts young lives short.

Biologists reprogram skin cells to mimic rare disease

Aug 21, 2014

Johns Hopkins stem cell biologists have found a way to reprogram a patient's skin cells into cells that mimic and display many biological features of a rare genetic disorder called familial dysautonomia. ...

User comments